YDL041W Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Context of YDL041W

YDL041W is a gene locus identifier in the Saccharomyces cerevisiae (budding yeast) genome, corresponding to a hypothetical open reading frame (ORF) without a characterized function. According to the Saccharomyces Genome Database (SGD) , YDL041W encodes a protein of unknown biological role, with no experimentally validated molecular or cellular functions. The gene is not associated with any known antibodies in the provided search results or mainstream antibody databases.

Lack of Evidence for an "YDL041W Antibody"

  • Search Results Analysis: None of the sources ( , ) mention antibodies targeting YDL041W.

  • Antibody-Specific Databases: The Antibody Society’s therapeutic antibody database ( ) and other literature on monoclonal antibodies ( , ) focus on human or pathogen-targeting antibodies (e.g., HIV, cancer), not yeast proteins.

  • Yeast Genome Resources: The SGD entry for YDL041W ( ) provides sequence and structural data but no references to antibody development or applications.

Possible Explanations for the Discrepancy

  • Misidentification: The term "YDL041W Antibody" may refer to a research reagent not widely documented in public databases.

  • Niche Research: Antibodies targeting yeast proteins are typically used in academic studies, but such antibodies are often cataloged by commercial suppliers (e.g., Thermo Fisher, Abcam) rather than in therapeutic databases.

Recommended Steps for Further Investigation

To address the lack of data in the provided sources:

  1. Consult Specialized Databases:

    • CiteAb: For research antibodies.

    • UniProt: To confirm YDL041W’s protein structure and potential epitopes.

  2. Review Yeast Proteome Studies: Investigate whether YDL041W has been characterized in recent publications.

  3. Contact Commercial Vendors: Inquire about custom antibodies against YDL041W.

Example Data Table (Hypothetical)

If an antibody against YDL041W were to exist, it might resemble the following profile:

ParameterDetails
Target AntigenYDL041W protein (S. cerevisiae)
Antibody TypePolyclonal or monoclonal
ApplicationsWestern blot, immunofluorescence
Commercial AvailabilityNot listed in major catalogs ( , )
Research CitationsNone identified in PubMed or SGD ( )

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YDL041W; D2717; Putative uncharacterized protein YDL041W
Target Names
YDL041W
Uniprot No.

Target Background

Database Links

STRING: 4932.YDL041W

Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YDL041W and why is an antibody against it important for research?

YDL041W is a gene locus identifier in the Saccharomyces cerevisiae (Baker's yeast) genome, corresponding to a hypothetical open reading frame (ORF) without a clearly characterized function. According to the Saccharomyces Genome Database, YDL041W encodes a protein of unknown biological role, with no experimentally validated molecular or cellular functions.

Antibodies against this protein are important research tools for:

  • Protein localization studies in yeast cells

  • Characterization of protein expression patterns under various conditions

  • Investigation of potential protein-protein interactions

  • Validation of protein function in knockout or modification studies

The study of hypothetical proteins like YDL041W is crucial for expanding our understanding of the yeast proteome and discovering novel cellular functions that may have broader implications in eukaryotic biology.

What are the general specifications of commercially available YDL041W antibodies?

The YDL041W antibody is available as a research reagent with the following specifications:

ParameterSpecification
TargetYDL041W protein from S. cerevisiae
UniProt NumberQ12352
Host SpeciesNot specified in sources
FormLiquid
Buffer Composition50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Preservative0.03% Proclin 300
Available Sizes2ml/0.1ml
Product CodeCSB-PA619588XA01SVG

The antibody is specifically designed to target the protein encoded by YDL041W in Saccharomyces cerevisiae strain ATCC 204508 / S288c, which is the standard laboratory strain of Baker's yeast .

What experimental applications are suitable for YDL041W antibody?

While specific application data for YDL041W antibody is limited in the available literature, based on standard antibody applications for similar yeast proteins, researchers can consider the following methodologies:

  • Western blotting for protein detection and quantification

  • Immunoprecipitation (IP) for protein isolation and interaction studies

  • Immunofluorescence (IF) for subcellular localization

  • Chromatin immunoprecipitation (ChIP) if the protein has DNA-binding properties

  • ELISA for quantitative analysis in cell or tissue extracts

  • Flow cytometry for single-cell protein expression studies

Researchers should validate the antibody for their specific application through appropriate controls, as the performance may vary across different experimental conditions and techniques.

How should researchers approach epitope mapping for YDL041W antibody validation?

For thorough validation of YDL041W antibodies, epitope mapping is crucial, especially given the hypothetical nature of this protein. A methodological approach would include:

Step 1: In silico analysis

  • Perform sequence analysis to identify potential antigenic regions

  • Use protein structure prediction tools to identify surface-exposed regions

  • Compare with conserved domains in related proteins

Step 2: Experimental mapping

  • Generate overlapping peptides spanning the YDL041W sequence

  • Perform peptide ELISA to identify reactive epitopes

  • Confirm using competitive binding assays

Step 3: Validation

  • Test antibody specificity using YDL041W deletion strains

  • Perform cross-reactivity tests with related yeast proteins

  • Validate using recombinant protein with site-directed mutations at key epitope residues

This rigorous approach is especially important for hypothetical proteins like YDL041W where functional domains have not been experimentally characterized, helping to establish both specificity and utility of the antibody in various research applications.

What are the methodological challenges in studying proteins of unknown function like YDL041W using antibodies?

Investigating hypothetical proteins like YDL041W presents several methodological challenges:

  • Confirmation of expression: Since YDL041W has no characterized function, researchers must first establish whether the protein is expressed under standard or specific conditions. Methodological approach:

    • Use the antibody for western blotting across different growth phases and stress conditions

    • Complement with RT-PCR to correlate protein detection with mRNA expression

    • Consider epitope tagging as an alternative verification method

  • Specificity validation: Without known biological activity to serve as a functional readout, confirming antibody specificity requires:

    • Generation of YDL041W knockout strains as negative controls

    • Preabsorption tests using recombinant YDL041W protein

    • Mass spectrometry identification of immunoprecipitated proteins

  • Biological context establishment: To gain insights into function:

    • Perform co-immunoprecipitation studies to identify interaction partners

    • Use the antibody for subcellular localization studies under various conditions

    • Combine with phenotypic analyses of deletion mutants

  • Cross-reactivity assessment: Evaluate potential cross-reactivity with homologous proteins through:

    • Sequence alignment analysis

    • Testing against recombinant proteins of related ORFs

    • Western blotting with extracts from strains with targeted gene deletions

Each of these challenges requires methodological rigor and multiple complementary approaches to generate reliable findings when working with antibodies against hypothetical proteins.

How can researchers optimize immunoprecipitation protocols for YDL041W protein interaction studies?

For successful immunoprecipitation of YDL041W and its interaction partners, researchers should consider this optimized protocol framework:

Buffer Optimization:

  • Test multiple lysis buffers varying in ionic strength (150-500mM NaCl)

  • Evaluate different detergent compositions (Triton X-100, NP-40, Digitonin)

  • Include protease inhibitor cocktails to prevent degradation

  • Consider phosphatase inhibitors if post-translational modifications are suspected

Cross-linking Considerations:

  • For transient interactions, implement formaldehyde cross-linking (0.1-1%)

  • Optimize cross-linking time (typically 5-15 minutes) to prevent over-fixation

  • Include glycine quenching step (125mM final concentration)

Antibody Coupling Strategy:

  • Direct coupling to beads (e.g., NHS-activated Sepharose) for cleaner results

  • Test different antibody amounts (1-10μg per reaction)

  • Compare Protein A/G beads with directly conjugated antibodies

Recommended Procedural Steps:

  • Harvest yeast cells from 50ml culture (OD600 ~0.8-1.0)

  • Lyse cells using glass bead disruption in optimized buffer

  • Clear lysate by centrifugation (20,000g, 15 min, 4°C)

  • Pre-clear with naked beads (1 hour, 4°C)

  • Incubate cleared lysate with antibody-coupled beads (overnight, 4°C)

  • Wash stringently (at least 5 times with increasing salt concentrations)

  • Elute under native conditions (for interaction studies) or denaturing conditions (for maximum yield)

  • Analyze by western blotting and mass spectrometry

This methodological framework should be adjusted based on initial results, with particular attention to buffer compositions that maintain native protein interactions while minimizing non-specific binding.

What controls should be included when using YDL041W antibody for Western blotting?

A robust Western blotting experiment using YDL041W antibody should include the following essential controls:

Positive Controls:

  • Recombinant YDL041W protein (if available)

  • Yeast strain overexpressing YDL041W

  • Epitope-tagged YDL041W strain (e.g., HA-tag, FLAG-tag)

Negative Controls:

  • YDL041W knockout strain lysate

  • Pre-immune serum in place of primary antibody

  • Primary antibody pre-absorbed with recombinant YDL041W protein

Loading Controls:

  • Housekeeping protein antibodies (e.g., anti-Pgk1, anti-Adh1)

  • Total protein stain (Ponceau S) on membrane before blocking

Protocol Validation Controls:

  • Gradient of lysate concentrations to establish detection limits

  • Time-course samples if expression is suspected to be condition-dependent

  • Positive control from a related characterized protein

These controls help researchers distinguish between specific signal and background noise, crucial when working with antibodies against hypothetical proteins like YDL041W where expected banding patterns may not be well-established in the literature.

How can researchers troubleshoot specificity issues with YDL041W antibody?

When encountering specificity issues with YDL041W antibody, follow this systematic troubleshooting approach:

Issue: Multiple bands on Western blot

Potential causes and solutions:

  • Protein degradation:

    • Add fresh protease inhibitors to lysis buffer

    • Reduce sample processing time and temperature

    • Use alternative extraction methods (e.g., TCA precipitation)

  • Cross-reactivity:

    • Increase blocking time and concentration (5% BSA or milk)

    • Optimize antibody dilution (test range from 1:500 to 1:5000)

    • Try alternative blocking agents (casein, commercial blockers)

    • Perform peptide competition assay with immunizing peptide

  • Post-translational modifications:

    • Use phosphatase treatment to confirm if bands represent phosphorylated forms

    • Test samples under various growth conditions to see if band pattern changes

    • Compare with epitope-tagged version of the protein

Issue: No signal detected

Potential causes and solutions:

  • Low expression level:

    • Increase protein loading (up to 50-100μg total protein)

    • Use enhanced chemiluminescence detection

    • Try concentration methods (e.g., immunoprecipitation before Western)

    • Test cells under stress conditions that might induce expression

  • Extraction issues:

    • Try different lysis methods (mechanical, detergent-based, enzymatic)

    • Optimize buffer conditions for subcellular fractionation

    • Check if the protein is in insoluble fraction

  • Epitope masking or destruction:

    • Test different sample preparation methods (native vs. denaturing)

    • Try membrane stripping and re-probing with alternative antibodies

    • Consider epitope retrieval methods

Systematic documentation of troubleshooting experiments is essential for building a reliable protocol for YDL041W detection, which will benefit the broader research community.

What strategies can be employed to determine the subcellular localization of YDL041W protein?

To determine the subcellular localization of the hypothetical YDL041W protein, researchers should consider a multi-method approach:

Immunofluorescence Microscopy:

  • Fix yeast cells with formaldehyde (3.7%, 30 minutes)

  • Digest cell wall with zymolyase/glusulase

  • Permeabilize with detergent (0.1% Triton X-100)

  • Block with BSA (3%, 1 hour)

  • Incubate with YDL041W antibody (overnight, 4°C)

  • Apply fluorescent secondary antibody

  • Counterstain with organelle markers:

    • DAPI for nucleus

    • MitoTracker for mitochondria

    • ER-Tracker for endoplasmic reticulum

    • FM4-64 for vacuole/endosomes

Subcellular Fractionation:

  • Perform differential centrifugation to separate cellular compartments:

    • 1,000g pellet (nuclei, cell wall)

    • 10,000g pellet (mitochondria, vacuoles)

    • 100,000g pellet (microsomes, ER, Golgi)

    • 100,000g supernatant (cytosol)

  • Analyze fractions by Western blotting with YDL041W antibody

  • Confirm fraction purity using compartment-specific markers:

    • Histone H3 (nucleus)

    • Porin (mitochondria)

    • Pma1 (plasma membrane)

    • Kar2 (ER)

    • Pgk1 (cytosol)

Complementary Approaches:

  • Generate GFP-fusion constructs for live-cell imaging

  • Perform immuno-electron microscopy for high-resolution localization

  • Use proximity-dependent biotin identification (BioID) to map protein neighborhood

When interpreting results, researchers should be aware that localization may change under different growth conditions or stress responses, necessitating analysis across multiple experimental conditions.

How should researchers interpret contradictory results between antibody-based detection and genetic studies of YDL041W?

When faced with contradictions between antibody-based detection and genetic studies of YDL041W, researchers should implement this analytical framework:

Step 1: Evaluate the nature of contradictions

  • Example scenario: Antibody detects protein expression but deletion shows no phenotype

  • Example scenario: Antibody shows nuclear localization but genetic fusion suggests cytoplasmic distribution

  • Example scenario: Antibody-based interactions differ from genetic interaction screens

Step 2: Assess technical limitations systematically

TechniquePotential LimitationsVerification Approach
Antibody detectionCross-reactivity, epitope masking, fixation artifactsValidate with tagged constructs, mass spectrometry identification
Gene deletionGenetic compensation, redundancy, subtle phenotypesRNA-seq of deletion strain, synthetic genetic arrays
Protein localizationOverexpression artifacts, tag interferenceCompare multiple tagging strategies, inducible expression systems
Interaction studiesFalse positives, buffer conditions affecting interactionsReciprocal IPs, in vitro binding assays

Step 3: Reconciliation strategies

  • Conditional expression analysis:

    • Test protein expression and function under various stress conditions

    • Use time-course experiments to capture dynamic changes

  • Orthogonal method validation:

    • Compare antibody results with CRISPR-based tagging approaches

    • Validate interactions with proximity-labeling techniques (BioID, APEX)

  • Quantitative assessment:

    • Apply ratiometric analysis to localization studies

    • Use quantitative proteomics to measure interaction stoichiometry

  • Evolutionary perspective:

    • Compare findings with homologs in related yeast species

    • Assess conservation of interactions and functions

Contradictions often reveal interesting biological complexity rather than experimental failure, and careful analysis may uncover condition-specific roles, moonlighting functions, or novel regulatory mechanisms for YDL041W.

What advanced bioinformatic approaches can complement antibody-based research on YDL041W?

To maximize insights from antibody-based studies of YDL041W, researchers should integrate the following bioinformatic approaches:

Structural Prediction and Analysis:

  • Generate 3D structure predictions using AlphaFold2 or RoseTTAFold

  • Identify potential functional domains through structural homology

  • Perform molecular dynamics simulations to predict flexible regions

  • Use structure-based epitope prediction to optimize antibody applications

Network Analysis:

  • Integrate YDL041W into protein-protein interaction networks

  • Apply guilt-by-association approaches to predict function

  • Use Bayesian integration of diverse -omics datasets

  • Generate testable hypotheses for antibody-based validation

Evolutionary Analysis:

  • Perform phylogenetic profiling across fungal species

  • Identify co-evolving gene pairs as potential functional partners

  • Analyze selection pressure on different regions of YDL041W

  • Predict functional importance based on evolutionary conservation

Expression Data Mining:

  • Analyze YDL041W expression patterns across public RNA-seq datasets

  • Identify co-expressed genes for functional inference

  • Use condition-specific expression to guide experimental design

  • Correlate expression with phenotypic data from high-throughput screens

Integrated Workflow Example:

  • Generate structure prediction of YDL041W

  • Identify potential binding sites or catalytic residues

  • Design experiments to test predictions using the antibody

  • Use antibody to pull down interaction partners

  • Validate predicted interactions from network analysis

  • Map interaction interfaces using structure-guided mutagenesis

This integrated approach helps researchers focus antibody-based experiments on the most promising hypotheses about YDL041W function, maximizing the value of limited research resources.

How can researchers establish the specificity of YDL041W antibody for reproducible chromatin immunoprecipitation (ChIP) experiments?

Establishing antibody specificity for ChIP experiments targeting YDL041W requires rigorous validation, especially as its potential DNA-binding properties are not well-characterized:

Pre-experimental Validation:

  • Epitope accessibility assessment:

    • Perform native vs. cross-linked Western blots

    • Test different cross-linking conditions (0.1-1% formaldehyde, 5-20 minutes)

    • Evaluate epitope masking in chromatin context

  • Specificity controls:

    • ChIP in YDL041W deletion strain (negative control)

    • ChIP in epitope-tagged YDL041W strain (parallel control)

    • Peptide competition assay with immunizing peptide

  • Chromatin preparation optimization:

    • Test sonication vs. enzymatic fragmentation methods

    • Optimize fragment size distribution (200-500bp ideal)

    • Evaluate different lysis conditions for chromatin accessibility

Experimental Validation Framework:

Validation StepMethodologySuccess Criteria
Input controlAnalyze non-immunoprecipitated chromatinEven coverage across genome
Mock IPPerform IP with non-specific IgGMinimal enrichment over background
Spike-in controlAdd foreign chromatin (e.g., Drosophila)Consistent recovery of spike-in
Serial dilutionTitrate antibody concentrationLinear relationship with signal
Technical replicatesRepeat IP from same chromatin preparationCorrelation coefficient >0.9
Biological replicatesIndependent cultures and preparationsConsistent peak patterns

Advanced Analytical Approaches:

  • Sequential ChIP (re-ChIP):

    • Perform first IP with YDL041W antibody

    • Elute and perform second IP with antibody against predicted interaction partner

    • Confirms co-occupancy at specific loci

  • ChIP-exo or ChIP-nexus:

    • Add exonuclease digestion step for base-pair resolution

    • Provides precise binding site information

    • Helps distinguish direct vs. indirect binding

  • Comparison with orthogonal methods:

    • Correlate ChIP peaks with CUT&RUN or CUT&Tag data

    • Validate with DNA-protein interaction methods (e.g., EMSA, DNA pull-down)

  • Motif analysis:

    • Identify enriched sequence motifs in peak regions

    • Compare with known transcription factor binding sites

    • Use for functional annotation of potential regulatory roles

Establishing these rigorous controls ensures that ChIP experiments with YDL041W antibody produce reliable and reproducible results that can withstand peer review scrutiny.

What are the best practices for using YDL041W antibody in co-immunoprecipitation studies to identify protein interaction partners?

For optimal co-immunoprecipitation (co-IP) results with YDL041W antibody, researchers should follow these methodological best practices:

Sample Preparation:

  • Harvest yeast cells at mid-log phase (OD600 ~0.8) for standard conditions

  • Consider testing multiple growth conditions to capture condition-specific interactions

  • Lyse cells gently using glass beads in non-denaturing buffer:

    • 50mM HEPES pH 7.5

    • 150mM NaCl (adjust based on interaction strength)

    • 1mM EDTA

    • 10% glycerol

    • 0.1-0.5% NP-40 (test different concentrations)

    • Protease inhibitor cocktail

    • Phosphatase inhibitors if phosphorylation is relevant

Co-IP Procedure Optimization:

  • Pre-clear lysate with protein A/G beads (1 hour, 4°C)

  • Set aside input control (5-10% of lysate)

  • Divide cleared lysate into experimental and control samples

  • Add YDL041W antibody to experimental sample (2-5μg)

  • Add non-specific IgG to control sample (same amount)

  • Incubate overnight at 4°C with gentle rotation

  • Add pre-washed protein A/G beads (30-50μl)

  • Incubate 2-4 hours at 4°C

  • Wash 5 times with buffer containing increasing salt concentrations (150-500mM)

  • Elute with gentle elution buffer or by boiling in SDS sample buffer

Validation and Analysis:

  • Confirm YDL041W pull-down by Western blotting a small portion (10%)

  • Use remaining sample for interaction partner identification:

    • SDS-PAGE followed by silver staining

    • In-gel digestion of differential bands

    • Mass spectrometry analysis

  • Confirm promising interactions by reverse co-IP

  • Validate with orthogonal methods (yeast two-hybrid, proximity labeling)

Advanced Strategies:

  • Use chemical crosslinking (DSP, formaldehyde) for transient interactions

  • Consider tandem affinity purification for cleaner results

  • Compare interactomes under different physiological conditions

  • Implement SILAC or TMT labeling for quantitative interactome analysis

This comprehensive approach maximizes the chance of identifying genuine interaction partners while minimizing experimental artifacts.

How can quantitative approaches enhance YDL041W antibody-based research?

Implementing quantitative methodologies significantly enhances the rigor and insights gained from YDL041W antibody-based research:

Quantitative Western Blotting:

  • Use infrared fluorescent secondary antibodies (IRDye 680/800)

  • Implement housekeeping protein normalization (e.g., Pgk1, Adh1)

  • Generate standard curves with recombinant protein

  • Apply densitometry analysis with appropriate software (ImageJ, Image Studio)

  • Include internal calibration controls on each blot

Quantitative Immunofluorescence:

  • Employ multichannel imaging for colocalization analysis

  • Perform Z-stack acquisition for 3D localization quantification

  • Use automated image analysis (CellProfiler, ImageJ macros)

  • Implement Pearson's or Manders' coefficients for colocalization quantification

  • Apply single-cell analysis to capture population heterogeneity

Quantitative Proteomics:

  • Implement SILAC labeling for comparative studies

  • Use tandem mass tag (TMT) labeling for multiplexed experiments

  • Apply absolute quantification (AQUA) with isotope-labeled peptides

  • Perform selected reaction monitoring (SRM) for targeted quantification

  • Integrate with parallel reaction monitoring (PRM) for verification

Example Experimental Design: Stress Response Quantification

ConditionApproachQuantitative OutputStatistical Analysis
Normal growthTime-course Western blottingNormalized YDL041W levelsANOVA with post-hoc tests
Oxidative stressImmunofluorescenceSubcellular distribution changesK-means clustering
Nutrient limitationQuantitative proteomicsInteraction partner dynamicsSAINT algorithm, FDR control
Cell cycle arrestFlow cytometryCell cycle-dependent expressionPropidium iodide correlation

Integration of Multiple Quantitative Datasets:

  • Correlate protein abundance with localization changes

  • Map interaction dynamics to functional outcomes

  • Build predictive models of YDL041W function

  • Generate quantitative hypotheses for targeted validation

These quantitative approaches transform descriptive observations into statistically robust, reproducible findings that can reveal subtle but significant aspects of YDL041W biology that might be missed by qualitative methods alone.

What considerations are important when using YDL041W antibody for flow cytometry applications?

When adapting YDL041W antibody for flow cytometry in yeast cells, researchers should address these specialized considerations:

Sample Preparation Optimization:

  • Cell wall removal:

    • Lyticase or zymolyase treatment (optimize concentration and time)

    • Monitor spheroplast formation microscopically

    • Use osmotic stabilizers (1M sorbitol) in all buffers

  • Fixation method selection:

    • Test formaldehyde (3.7%, 15-30 min) vs. methanol (-20°C, 10 min)

    • Evaluate epitope preservation with each method

    • Consider dual fixation for challenging epitopes

  • Permeabilization optimization:

    • Titrate detergent concentration (0.1-0.5% Triton X-100)

    • Test alternative detergents (saponin, digitonin)

    • Optimize temperature and duration

Staining Protocol Development:

  • Blocking optimization:

    • Test different blocking agents (BSA, normal serum, commercial blockers)

    • Determine optimal concentration (3-5%)

    • Include Fc receptor blocking if using Fc-expressing yeast

  • Antibody titration:

    • Perform serial dilutions (typically 1:50 to 1:1000)

    • Generate signal-to-noise ratio curves

    • Determine optimal concentration for specific detection

  • Secondary antibody selection:

    • Choose fluorophores compatible with available lasers

    • Consider brightness requirements (PE, APC for dim signals)

    • Test for cross-reactivity with yeast proteins

Controls and Validation:

Control TypePurposeImplementation
UnstainedAutofluorescence baselineProcess cells without any antibodies
Secondary onlyBackground from secondary antibodyOmit primary antibody
Isotype controlNon-specific binding assessmentUse matched isotype antibody
Positive controlValidate staining procedureUse epitope-tagged YDL041W strain
Negative controlConfirm specificityUse YDL041W deletion strain
Competitive inhibitionEpitope validationPre-incubate antibody with immunizing peptide

Advanced Applications:

  • Multi-parameter analysis:

    • Combine with cell cycle markers (propidium iodide)

    • Add mitochondrial or vacuolar dyes for organelle correlation

    • Include viability markers (e.g., PI exclusion)

  • Phosphorylation state analysis:

    • Use phospho-specific antibodies if available

    • Compare total vs. phospho-protein levels

    • Correlate with cell cycle or stress responses

  • Sorting considerations:

    • Optimize buffer composition for spheroplast stability

    • Use lower pressure settings to prevent cell disruption

    • Collect into recovery media containing osmotic stabilizers

These methodological considerations ensure reliable and reproducible flow cytometry data when working with the YDL041W antibody in yeast cells, enabling quantitative single-cell analysis of this hypothetical protein.

How might YDL041W antibody contribute to understanding stress response mechanisms in yeast?

YDL041W antibody can serve as a valuable tool for investigating potential roles of this hypothetical protein in yeast stress response through these methodological approaches:

Expression Profiling Across Stress Conditions:

  • Use quantitative Western blotting to measure YDL041W levels under:

    • Oxidative stress (H₂O₂, menadione)

    • Heat shock (37-42°C)

    • Osmotic stress (NaCl, sorbitol)

    • Nutrient limitation (nitrogen, carbon, phosphate)

    • DNA damage (UV, MMS, hydroxyurea)

    • ER stress (tunicamycin, DTT)

Dynamic Localization Studies:

  • Track subcellular redistribution using immunofluorescence:

    • Monitor nuclear-cytoplasmic shuttling

    • Assess association with stress granules or P-bodies

    • Examine co-localization with known stress response factors

    • Implement time-lapse imaging in tagged strains to complement antibody studies

Stress-Specific Interactome Analysis:

  • Perform comparative co-IPs under normal vs. stress conditions

  • Identify condition-specific interaction partners

  • Map YDL041W into stress response networks

  • Correlate interactome changes with functional outcomes

Post-Translational Modification Assessment:

  • Analyze stress-induced modifications using:

    • Phospho-specific antibodies (if available)

    • Mobility shift detection

    • Mass spectrometry after immunoprecipitation

    • 2D gel electrophoresis with YDL041W antibody detection

Functional Complementation Studies:

  • Assess whether YDL041W-deleted strains show stress sensitivity

  • Use the antibody to confirm expression of wild-type vs. mutant proteins

  • Correlate protein levels with phenotypic rescue

  • Analyze protein-protein interactions in complemented strains

Comparative Analysis with Known Stress Response Factors:

  • Examine co-regulation with Msn2/4, Hsf1, or Yap1 targets

  • Assess interdependence of expression patterns

  • Investigate potential physical interactions

  • Determine whether YDL041W functions upstream or downstream of known pathways

This systematic investigation using YDL041W antibody as a primary tool could potentially reveal novel stress response mechanisms and assign a function to this hypothetical protein, contributing significantly to our understanding of yeast cellular resilience.

What techniques could researchers employ to study potential post-translational modifications of YDL041W?

To comprehensively investigate post-translational modifications (PTMs) of YDL041W, researchers should implement this multi-technique strategy:

Initial PTM Screening:

  • Gel Mobility Analysis:

    • Compare migration patterns under different conditions

    • Use Phos-tag gels to detect phosphorylation-dependent mobility shifts

    • Apply 2D gel electrophoresis to separate charge and mass variants

  • Treatment with Modifying/Demodifying Enzymes:

    • Phosphatase treatment (CIP, lambda phosphatase)

    • Deglycosylation enzymes (PNGase F, Endo H)

    • Deubiquitinating enzymes (USP2, USP21)

    • Observe mobility changes by Western blotting with YDL041W antibody

PTM-Specific Detection Methods:

PTM TypeDetection ApproachAnalytical Method
PhosphorylationPhospho-specific antibodiesWestern blot, immunoprecipitation
Phospho-protein stainingPro-Q Diamond staining
Radioisotope labeling³²P incorporation
UbiquitinationEpitope-tagged ubiquitinCo-IP followed by Western blot
TUBEs (tandem ubiquitin binding entities)Affinity purification
AcetylationPan-acetyl-lysine antibodiesWestern blot after IP
GlycosylationLectins (ConA, WGA)Lectin blotting, affinity purification
SUMOylationSUMO-specific antibodiesWestern blot after denaturing IP

Mass Spectrometry-Based Approaches:

  • Sample Preparation:

    • Immunoprecipitate YDL041W using validated antibody

    • Perform in-gel or in-solution digestion

    • Enrich for specific PTMs:

      • TiO₂ for phosphopeptides

      • Lectins for glycopeptides

      • Antibody-based enrichment for acetylated or ubiquitinated peptides

  • MS Analysis Strategies:

    • Data-dependent acquisition for discovery

    • Parallel reaction monitoring for targeted analysis

    • Electron transfer dissociation for labile modifications

    • Top-down proteomics for intact protein analysis

  • Bioinformatic Analysis:

    • PTM site localization algorithms

    • Motif analysis for kinase/enzyme prediction

    • Structural mapping of modified residues

    • Integration with known modification databases

Functional Validation of PTMs:

  • Generate point mutants at identified sites (e.g., S→A or S→E for phosphorylation)

  • Express in YDL041W deletion background

  • Assess functional consequences through phenotypic assays

  • Confirm expression and modification status using the antibody

  • Determine effects on protein-protein interactions and localization

This comprehensive approach enables researchers to identify and characterize the functional relevance of PTMs on YDL041W, potentially revealing regulatory mechanisms and functional insights into this hypothetical protein.

How can emerging technologies enhance the utility of YDL041W antibody for comprehensive protein characterization?

Emerging technologies offer powerful new approaches to leverage YDL041W antibody for deeper protein characterization:

Proximity Labeling Technologies:

  • BioID approach:

    • Generate YDL041W-BirA fusion

    • Validate expression using YDL041W antibody

    • Compare biotinylated proteins with traditional co-IP results

    • Identify transient or weak interactors missed by conventional methods

  • APEX2 system:

    • Create YDL041W-APEX2 fusion for rapid proximity labeling

    • Confirm proper localization using YDL041W antibody

    • Map spatial protein interactions with subcellular resolution

    • Perform time-resolved interactome analysis under varying conditions

Advanced Microscopy Applications:

  • Super-resolution microscopy:

    • Implement STORM/PALM using directly labeled YDL041W antibody

    • Achieve nanoscale resolution of protein distribution

    • Perform quantitative cluster analysis

    • Correlate with functional cellular landmarks

  • Live-cell nanobody adaptations:

    • Develop nanobodies based on YDL041W antibody epitopes

    • Validate against conventional antibody detection

    • Enable real-time tracking of native protein

    • Combine with optogenetic tools for functional perturbation

Single-Cell Technologies:

  • Single-cell proteomics:

    • Apply microfluidic antibody capture for YDL041W detection

    • Correlate with single-cell transcriptomics

    • Identify cell-to-cell variability in expression

    • Map protein levels to phenotypic heterogeneity

  • Mass cytometry (CyTOF):

    • Label YDL041W antibody with rare earth metals

    • Combine with dozens of other cellular markers

    • Create high-dimensional profiles of cellular states

    • Identify conditional relationships between YDL041W and cellular pathways

Integrative Structural Biology:

  • Antibody-assisted cryo-EM:

    • Use YDL041W antibody as fiducial marker

    • Enhance particle alignment and orientation determination

    • Potentially stabilize flexible regions for improved resolution

    • Map antibody binding site to validate structural predictions

  • Cross-linking mass spectrometry:

    • Employ antibody for protein complex isolation

    • Apply chemical cross-linking to capture interaction interfaces

    • Identify structural constraints for protein modeling

    • Integrate with AlphaFold2 predictions for refined structures

Protein Engineering Applications:

  • Intrabody development:

    • Engineer YDL041W antibody for intracellular expression

    • Create conditional protein knockdown systems

    • Validate with conventional antibody detection

    • Study acute vs. chronic protein depletion effects

  • Split-protein complementation:

    • Develop antibody-based protein fragment complementation assays

    • Monitor protein interactions in living cells

    • Create biosensors for YDL041W conformational changes

    • Detect protein-protein interactions with spatial resolution

These innovative technologies significantly extend the utility of YDL041W antibody beyond conventional applications, enabling researchers to gain unprecedented insights into the structure, function, interactions, and dynamics of this hypothetical yeast protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.